Targeting Schistosome Histone Modifying Enzymes for Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|24|3567-3578

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.24, 2012-08, pp. : 3567-3578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance

By  

Current Medicinal Chemistry, Vol. 24, Iss. 26, 2017-09 ,pp. : 2860-2886

Bentham Science Publishers

Access to resources Recommend Favorite

The Redox Biology of Schistosome Parasites and Applications for Drug Development

By  

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3595-3611

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Drug Discovery Targeting Histone Methyltransferases: An Update

By  

Current Medicinal Chemistry, Vol. 22, Iss. 17, 2015-06 ,pp. : 2075-2086

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Plasmodium Falciparum Purine Salvage Enzymes: A Look At Structure-Based Drug Development

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 3, 2010-06 ,pp. : 191-199

Bentham Science Publishers

Access to resources Recommend Favorite

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

By Gore S.D.   Carducci M.A.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2923-2934

Informa Healthcare

Access to resources Recommend Favorite